Fig. 5.
![Fig. 5. PCR analysis of normal peripheral blood leukocyte (PBL) cDNA, cDNA from patient UPN 04 [inv(8)] and a MOZ-CBP positive control [t(8; 16)]. Primer combinations used were: MOZ-CBP, MOZ-6 + CBP-1; CBP-MOZ, CBP-4 + MOZ-7; MOZ, MOZ-6 + MOZ-7; CBP, CBP-4 + CBP-1. Sizes of PCR products are indicated.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/8/10.1182_blood.v90.8.3130/4/bl_0012f5.jpeg?Expires=1735519262&Signature=anp1Rj~sLu-Nq~Xr9GKWrODPnOOnHtJJ-Dvy0QrNaaLImczgWL6lqIhwESqhm2lRzKfW-DVAB0ewbE5spRyEgTZlT0WZWvsYBKG1dVQJ-re9iTIlIt58T0icl4HYXSkvXl2TcSdmXmuINarDrt6GsVsW-spVKNftpITXFnxM2XLn5m5LXVxs4ZVmjdpaDMqNTIfRTEiijyPEjLVh34JR6ufG4H8pXT~9rmccQmv5a0txmQIoTGKEICR712LyNaG11-Bk7ZTesf7OuMecmraGTIzGl82dCSkROvrPksKJnH-F5FjdxI3vla-vWCaplSxSDk8mqjbgvHjVlzcvxre8Qw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PCR analysis of normal peripheral blood leukocyte (PBL) cDNA, cDNA from patient UPN 04 [inv(8)] and a MOZ-CBP positive control [t(8; 16)]. Primer combinations used were: MOZ-CBP, MOZ-6 + CBP-1; CBP-MOZ, CBP-4 + MOZ-7; MOZ, MOZ-6 + MOZ-7; CBP, CBP-4 + CBP-1. Sizes of PCR products are indicated.
